# Trial of Linaclotide in Patients With Chronic Idiopathic Constipation

> **NCT02291679** · PHASE3 · COMPLETED · sponsor: **Ironwood Pharmaceuticals, Inc.** · enrollment: 1223 (actual)

## Conditions studied

- Chronic Idiopathic Constipation

## Interventions

- **DRUG:** Linaclotide
- **DRUG:** Matching Placebo

## Key facts

- **NCT ID:** NCT02291679
- **Lead sponsor:** Ironwood Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-10
- **Primary completion:** 2015-08
- **Final completion:** 2015-08
- **Target enrollment:** 1223 (ACTUAL)
- **Last updated:** 2017-06-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02291679

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02291679, "Trial of Linaclotide in Patients With Chronic Idiopathic Constipation". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02291679. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
